Vaccine Induced Cancer
A strong association between non-Hodgkin lymphoma and simian virus 40
"Our data indicate a strong association between non Hodgkin's lyphoma and SV40 and thus a need for innovative therapeutic approaches for this hematologic malignancy."
A group of researchers from the Section of Pathology, Oncology, and Experimental Biology, School of Medicine, University of Ferrara, Ferrara, Italy, published the results of their research in the April, 2015 issue of "Cancer," the journal of the American Cancer Society.
SV 40 is a virus found in the monkey kidneys used to culture some vaccines.
Click here to read the abstract of their study.
A group of researchers from the Section of Pathology, Oncology, and Experimental Biology, School of Medicine, University of Ferrara, Ferrara, Italy, published the results of their research in the April, 2015 issue of "Cancer," the journal of the American Cancer Society.
SV 40 is a virus found in the monkey kidneys used to culture some vaccines.
Click here to read the abstract of their study.
FDA: Vaccines grown on cancer tissue
Vaccines grown on cancer tumors? Here are briefing notes from an FDA meeting on the subject.
"The Committee accepted the use of tumorigenic MDCK (dog kidney) cells for inactivated influenza vaccines and their evaluation in clinical trials." Pg 6
"Over the last 20 years, it has been recognized that cell lines derived from tumors may be the optimal and in some cases the only cell substrate that can be used to propagate certain vaccine viruses." Pg 7
"the possibility of unknown oncogenic factors remains as a theoretical concern with cells derived from human tissues" Pg 11
"The use of human tumor-derived cell lines poses added safety concerns regarding the potential presence of unexpected and unknown viruses... which exist normally in a quiescent state in the host cell DNA of all species, but can become activated and produce virus particles in tumor cell lines" Pg 12
"A major concern about residual cell-substrate DNA has been the potential for the induction of cancer, particularly if the DNA was from a tumorigenic cell or from a cell line established from a human cancer." Pg 16
"Integration was a concern when DNA vaccines were developed in the 1990s, and a VRBPAC meeting was convened in 1997 to discuss the issue. It was decided that it was unlikely that DNA integration occurred at a high enough frequency to be a concern, although no data were available at the time." (Many childhood cancers are related to vaccines.)
Click here to read these few highlights and the entire thirty page record from the "FDA Briefing Document Vaccines and Related Biological Products Advisory Committee Meeting, September 19, 2012: Cell Lines Derived from Human Tumors for Vaccine Manufacture."
"The Committee accepted the use of tumorigenic MDCK (dog kidney) cells for inactivated influenza vaccines and their evaluation in clinical trials." Pg 6
"Over the last 20 years, it has been recognized that cell lines derived from tumors may be the optimal and in some cases the only cell substrate that can be used to propagate certain vaccine viruses." Pg 7
"the possibility of unknown oncogenic factors remains as a theoretical concern with cells derived from human tissues" Pg 11
"The use of human tumor-derived cell lines poses added safety concerns regarding the potential presence of unexpected and unknown viruses... which exist normally in a quiescent state in the host cell DNA of all species, but can become activated and produce virus particles in tumor cell lines" Pg 12
"A major concern about residual cell-substrate DNA has been the potential for the induction of cancer, particularly if the DNA was from a tumorigenic cell or from a cell line established from a human cancer." Pg 16
"Integration was a concern when DNA vaccines were developed in the 1990s, and a VRBPAC meeting was convened in 1997 to discuss the issue. It was decided that it was unlikely that DNA integration occurred at a high enough frequency to be a concern, although no data were available at the time." (Many childhood cancers are related to vaccines.)
Click here to read these few highlights and the entire thirty page record from the "FDA Briefing Document Vaccines and Related Biological Products Advisory Committee Meeting, September 19, 2012: Cell Lines Derived from Human Tumors for Vaccine Manufacture."
Aluminum Linked to Breast Cancer: Literature Review
"Evidence is also reviewed that Al can enable the development of multiple hallmarks associated with cancer in breast cells, in particular that it can cause genomic instability and inappropriate proliferation in human breast epithelial cells, and can increase migration and invasion of human breast cancer cells. In addition, Al is a metalloestrogen and oestrogen is a risk factor for breast cancer known to influence multiple hallmarks. The microenvironment is established as another determinant of breast cancer development and Al has been shown to cause adverse alterations to the breast microenvironment."
This study was focusing on under arm antiperspirants but also looked closely at biomechanisms of aluminum injury and how they lead to cancer.
Click here to read the abstract of the study published in March, 2016 in the journal, "Morphologie" by a researcher in the School of Biological Sciences in the University of Reading in the U.K.
This study was focusing on under arm antiperspirants but also looked closely at biomechanisms of aluminum injury and how they lead to cancer.
Click here to read the abstract of the study published in March, 2016 in the journal, "Morphologie" by a researcher in the School of Biological Sciences in the University of Reading in the U.K.